National Institutes of Health Grant for Preclinical Proof-of-Concept Studies for Rare Diseases
SynopsisVersion HistoryRelated DocumentsPackage The National Institutes of Health is offering this grant to support preclinical proof-of-concept studies for rare diseases. This funding specifically targets efficacy studies in established rare disease models, demonstrating that proposed therapeutic agents (small molecules, biologics, or biotechnology products) warrant further development. Accompanying pharmacodynamic and pharmacokinetic studies are also supported. The grant's primary purpose is to accelerate therapeutic development for various rare conditions. By advancing projects to a [...]